A detailed history of Bfsg, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bfsg, LLC holds 1,000 shares of NVS stock, worth $104,870. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,000
Previous 1,012 1.19%
Holding current value
$104,870
Previous $107,000 7.48%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$106.13 - $120.89 $1,273 - $1,450
-12 Reduced 1.19%
1,000 $115,000
Q2 2024

Jul 29, 2024

BUY
$92.57 - $107.37 $925 - $1,073
10 Added 1.0%
1,012 $107,000
Q1 2024

Apr 23, 2024

BUY
$95.27 - $108.47 $3,810 - $4,338
40 Added 4.16%
1,002 $96,000
Q4 2023

Feb 01, 2024

BUY
$92.27 - $101.54 $88,763 - $97,681
962 New
962 $97,000
Q1 2022

May 04, 2022

SELL
$80.11 - $90.62 $231,117 - $261,438
-2,885 Closed
0 $0
Q4 2021

Jan 24, 2022

SELL
$79.7 - $88.13 $84,083 - $92,977
-1,055 Reduced 26.78%
2,885 $252,000
Q3 2021

Nov 03, 2021

BUY
$81.78 - $95.14 $322,213 - $374,851
3,940 New
3,940 $322,000
Q2 2021

Jul 29, 2021

SELL
$85.24 - $94.15 $420,233 - $464,159
-4,930 Closed
0 $0
Q1 2021

Apr 26, 2021

SELL
$83.5 - $98.47 $258,015 - $304,272
-3,090 Reduced 38.53%
4,930 $421,000
Q4 2020

Jan 26, 2021

BUY
$78.07 - $94.43 $17,565 - $21,246
225 Added 2.89%
8,020 $757,000
Q3 2020

Nov 04, 2020

BUY
$82.14 - $91.0 $67,354 - $74,620
820 Added 11.76%
7,795 $678,000
Q2 2020

Jul 22, 2020

SELL
$80.93 - $91.1 $26,706 - $30,062
-330 Reduced 4.52%
6,975 $609,000
Q1 2020

Apr 27, 2020

SELL
$70.67 - $99.01 $10,600 - $14,851
-150 Reduced 2.01%
7,305 $602,000
Q4 2019

Jan 29, 2020

SELL
$84.35 - $95.37 $8,435 - $9,537
-100 Reduced 1.32%
7,455 $706,000
Q3 2019

Oct 25, 2019

BUY
$85.54 - $94.26 $56,456 - $62,211
660 Added 9.57%
7,555 $655,000
Q2 2019

Jul 30, 2019

BUY
$75.4 - $92.8 $100,809 - $124,073
1,337 Added 24.06%
6,895 $630,000
Q4 2018

Jan 24, 2019

SELL
$73.66 - $82.02 $7,366 - $8,202
-100 Reduced 1.77%
5,558 $477,000
Q3 2018

Oct 18, 2018

SELL
$66.94 - $77.43 $52,547 - $60,782
-785 Reduced 12.18%
5,658 $487,000
Q2 2018

Jul 31, 2018

BUY
$64.91 - $73.36 $4,738 - $5,355
73 Added 1.15%
6,443 $487,000
Q1 2018

May 08, 2018

SELL
$70.39 - $84.15 $7,039 - $8,415
-100 Reduced 1.55%
6,370 $515,000
Q4 2017

Jan 23, 2018

BUY
$72.33 - $77.64 $52,800 - $56,677
730 Added 12.72%
6,470 $543,000
Q3 2017

Oct 12, 2017

BUY
$74.14 - $77.27 $31,509 - $32,839
425 Added 8.0%
5,740 $493,000
Q2 2017

Aug 10, 2017

BUY
N/A
5,315
5,315 $444,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $226B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bfsg, LLC Portfolio

Follow Bfsg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bfsg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bfsg, LLC with notifications on news.